336 related articles for article (PubMed ID: 21147981)
21. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.
Rogers JT; Morganti JM; Bachstetter AD; Hudson CE; Peters MM; Grimmig BA; Weeber EJ; Bickford PC; Gemma C
J Neurosci; 2011 Nov; 31(45):16241-50. PubMed ID: 22072675
[TBL] [Abstract][Full Text] [Related]
22. Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
Hsiao YH; Kuo JR; Chen SH; Gean PW
Neurobiol Dis; 2012 Mar; 45(3):1111-20. PubMed ID: 22227002
[TBL] [Abstract][Full Text] [Related]
23. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
24. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
[TBL] [Abstract][Full Text] [Related]
25. The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior.
Klevanski M; Herrmann U; Weyer SW; Fol R; Cartier N; Wolfer DP; Caldwell JH; Korte M; Müller UC
J Neurosci; 2015 Dec; 35(49):16018-33. PubMed ID: 26658856
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
[TBL] [Abstract][Full Text] [Related]
27. Cognitive deficits associated with alteration of synaptic metaplasticity precede plaque deposition in AβPP23 transgenic mice.
Balducci C; Tonini R; Zianni E; Nazzaro C; Fiordaliso F; Salio M; Vismara L; Gardoni F; Di Luca M; Carli M; Forloni G
J Alzheimers Dis; 2010; 21(4):1367-81. PubMed ID: 21504138
[TBL] [Abstract][Full Text] [Related]
28. Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.
Wang Y; Wu L; Li J; Fang D; Zhong C; Chen JX; Yan SS
J Alzheimers Dis; 2015; 43(2):451-63. PubMed ID: 25096625
[TBL] [Abstract][Full Text] [Related]
29. Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease.
McIntire LB; Berman DE; Myaeng J; Staniszewski A; Arancio O; Di Paolo G; Kim TW
J Neurosci; 2012 Oct; 32(44):15271-6. PubMed ID: 23115165
[TBL] [Abstract][Full Text] [Related]
30. Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease.
Lee SH; Kim KR; Ryu SY; Son S; Hong HS; Mook-Jung I; Lee SH; Ho WK
J Neurosci; 2012 Apr; 32(17):5953-63. PubMed ID: 22539855
[TBL] [Abstract][Full Text] [Related]
31. Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.
Fowler SW; Chiang AC; Savjani RR; Larson ME; Sherman MA; Schuler DR; Cirrito JR; Lesné SE; Jankowsky JL
J Neurosci; 2014 Jun; 34(23):7871-85. PubMed ID: 24899710
[TBL] [Abstract][Full Text] [Related]
32. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.
Dong H; Murphy KM; Meng L; Montalvo-Ortiz J; Zeng Z; Kolber BJ; Zhang S; Muglia LJ; Csernansky JG
J Alzheimers Dis; 2012; 28(3):579-92. PubMed ID: 22045495
[TBL] [Abstract][Full Text] [Related]
33. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
[TBL] [Abstract][Full Text] [Related]
34. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
35. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
36. Improvement of cognitive function in Alzheimer's disease model mice by genetic and pharmacological inhibition of the EP(4) receptor.
Hoshino T; Namba T; Takehara M; Murao N; Matsushima T; Sugimoto Y; Narumiya S; Suzuki T; Mizushima T
J Neurochem; 2012 Mar; 120(5):795-805. PubMed ID: 22044482
[TBL] [Abstract][Full Text] [Related]
37. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
38. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.
Caccamo A; De Pinto V; Messina A; Branca C; Oddo S
J Neurosci; 2014 Jun; 34(23):7988-98. PubMed ID: 24899720
[TBL] [Abstract][Full Text] [Related]
39. Impaired β-amyloid secretion in Alzheimer's disease pathogenesis.
Tampellini D; Rahman N; Lin MT; Capetillo-Zarate E; Gouras GK
J Neurosci; 2011 Oct; 31(43):15384-90. PubMed ID: 22031884
[TBL] [Abstract][Full Text] [Related]
40. Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
Yi JH; Baek SJ; Heo S; Park HJ; Kwon H; Lee S; Jung J; Park SJ; Kim BC; Lee YC; Ryu JH; Kim DH
Neuropharmacology; 2018 Jan; 128():282-292. PubMed ID: 29079294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
